4 Sep07:42 Business IceCure Medical Stock Has Fallen 93% in a Year — So Why Are Analysts Still Setting Price Targets Above $20? A version of the IceCure Medical narrative presents itself as a true success in medical technology. The company has been increasing its presence in American hospitals with its ProSense Cryoablation… News Team · 4 Sep